# Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder

> **NCT00662259** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 32 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Alprazolam (Xanax)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00662259
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00662259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00662259, "Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00662259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*